Condition
Cancer
Estimated Enrollment: 22
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 2009/337
Study First Received: October 15, 2009
Last Updated: February 7, 2017
Estimated Primary Completion Date: September 2015
Primary Outcome Measures:
Progression fee survival rate|Response rate according to modified RECIST criteria|Toxicity (CTCAE version 4)|Overall survival
Sponsors and Collaborators:
University Hospital, Ghent|Merck Sharp & Dohme Corp.
Website Link: https://ClinicalTrials.gov/show/NCT00996567
